人类免疫缺陷病毒相关卡波西肉瘤的最新进展
Recent advances in HIV-associated Kaposi sarcoma.
作者信息
Dalla Pria Alessia, Pinato David J, Bracchi Margherita, Bower Mark
机构信息
Imperial College London, London, UK.
Chelsea and Westminster Hospital, London, UK.
出版信息
F1000Res. 2019 Jun 26;8. doi: 10.12688/f1000research.17401.1. eCollection 2019.
Abstract
Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defining illness. Despite a decline in incidence since the introduction of combination anti-retroviral therapy, KS remains the most common cancer in people living with HIV in sub-Saharan Africa, where it causes significant morbidity and mortality. This review reflects on recent epidemiological data as well as current management, unmet needs and future perspectives in the treatment of HIV-associated KS with particular emphasis on the potential role of immune checkpoint inhibitors.
摘要
卡波西肉瘤（KS）是一种由卡波西肉瘤相关疱疹病毒引起的间充质肿瘤，是一种艾滋病界定疾病。尽管自联合抗逆转录病毒疗法引入以来发病率有所下降，但KS仍然是撒哈拉以南非洲地区艾滋病毒感染者中最常见的癌症，在该地区它会导致严重的发病率和死亡率。本综述回顾了近期的流行病学数据以及目前在治疗艾滋病毒相关KS方面的管理、未满足的需求和未来展望，特别强调了免疫检查点抑制剂的潜在作用。
相似文献
1
Recent advances in HIV-associated Kaposi sarcoma.
F1000Res. 2019 Jun 26;8. doi: 10.12688/f1000research.17401.1. eCollection 2019.
2
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
AIDS. 2013 Jun 19;27(10):1603-13. doi: 10.1097/QAD.0b013e328360a5a1.
3
Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
Cancer Epidemiol. 2022 Jun;78:102167. doi: 10.1016/j.canep.2022.102167. Epub 2022 Apr 30.
4
HIV-associated Kaposi sarcoma in African children.
SADJ. 2010 Feb;65(1):20-2.
5
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
Clin Infect Dis. 2016 Nov 1;63(9):1245-1253. doi: 10.1093/cid/ciw519. Epub 2016 Aug 30.
6
Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.
Pediatr Blood Cancer. 2016 Aug;63(8):1325-31. doi: 10.1002/pbc.26021. Epub 2016 Apr 15.
7
Diagnosis and Treatment of Kaposi Sarcoma.
Am J Clin Dermatol. 2017 Aug;18(4):529-539. doi: 10.1007/s40257-017-0270-4.
8
Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
BMC Cancer. 2017 Sep 2;17(1):611. doi: 10.1186/s12885-017-3549-1.
9
Facing up to the ongoing challenge of Kaposi's sarcoma.
Curr Opin Infect Dis. 2015 Feb;28(1):31-40. doi: 10.1097/QCO.0000000000000122.
10
Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on.
J Clin Oncol. 2022 Jan 20;40(3):294-306. doi: 10.1200/JCO.21.02040. Epub 2021 Dec 10.
引用本文的文献
1
Identification of new natural compounds against KSHV-related malignancies.
Am J Cancer Res. 2025 May 15;15(5):2170-2179. doi: 10.62347/VBVM8666. eCollection 2025.
2
Outcomes and prognostic factors of tonsillar Kaposi sarcoma in the United States SEER Database.
Ann Med Surg (Lond). 2025 Apr 22;87(6):3102-3106. doi: 10.1097/MS9.0000000000003294. eCollection 2025 Jun.
3
Cancer and HIV: The Molecular Mechanisms of the Deadly Duo.
Cancers (Basel). 2024 Jan 26;16(3):546. doi: 10.3390/cancers16030546.
4
Malignancy and viral infections in Sub-Saharan Africa: A review.
Front Virol. 2023;3. doi: 10.3389/fviro.2023.1103737. Epub 2023 Mar 6.
5
The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi's Sarcoma Tumors during Antiretroviral Therapy.
Viruses. 2022 Dec 13;14(12):2774. doi: 10.3390/v14122774.
6
Pneumonia or Kaposi Sarcoma: Beneath the Dyspnea With Non-compliance of HIV.
Cureus. 2022 Oct 10;14(10):e30152. doi: 10.7759/cureus.30152. eCollection 2022 Oct.
7
Spotlight on ocular Kaposi's sarcoma: an update on the presentation, diagnosis, and management options.
Expert Rev Ophthalmol. 2021;16(6):477-489. doi: 10.1080/17469899.2021.1962294. Epub 2021 Aug 11.
8
Human Gammaherpesvirus 8 Oncogenes Associated with Kaposi's Sarcoma.
Int J Mol Sci. 2022 Jun 29;23(13):7203. doi: 10.3390/ijms23137203.
9
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review.
Infect Dis Rep. 2022 Mar 25;14(2):228-242. doi: 10.3390/idr14020028.
10
Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma.
Cancers (Basel). 2022 Feb 16;14(4):986. doi: 10.3390/cancers14040986.
本文引用的文献
1
Decreased levels of the serum inflammatory biomarkers, sGP130, IL-6, sCRP and BAFF, are associated with increased likelihood of AIDS related Kaposi's sarcoma in men who have sex with men.
Cancer Res Front. 2018;4(1):45-59. doi: 10.17980/2018.45.
2
Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.02035-18. Print 2019 Mar 1.
3
Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade.
Cancer Immunol Res. 2018 Oct;6(10):1129-1135. doi: 10.1158/2326-6066.CIR-18-0121. Epub 2018 Sep 7.
4
Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.
Ann Oncol. 2018 Oct 1;29(10):2141-2142. doi: 10.1093/annonc/mdy259.
5
PD-1 blockade with nivolumab in endemic Kaposi sarcoma.
Ann Oncol. 2018 Apr 1;29(4):1067-1069. doi: 10.1093/annonc/mdy006.
6
Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.
Ann Oncol. 2018 Feb 1;29(2):517-518. doi: 10.1093/annonc/mdx696.
7
Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
mBio. 2017 Oct 10;8(5):e00917-17. doi: 10.1128/mBio.00917-17.
8
Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study.
Oncoimmunology. 2017 Apr 7;6(8):e1304337. doi: 10.1080/2162402X.2017.1304337. eCollection 2017.
9
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.
AIDS. 2017 Apr 24;31(7):1048-1051. doi: 10.1097/QAD.0000000000001429.
10
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.
J Clin Oncol. 2016 Dec;34(34):4125-4131. doi: 10.1200/JCO.2016.69.3812. Epub 2016 Oct 31.
Zotero 插件